LTX-315

LTX-315 peptide

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LTX-315, covering 2012-01-11 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma [Phase 2]